Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients

Masayuki Akashi, Hiroki Yasudo, Masami Narita, Ichiro Nomura, Akira Akasawa, Motohiro Ebisawa, Takao Takahashi, Yukihiro Ohya

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Egg allergy is one of the most common food allergies in young children. While oral immunotherapy (OIT) is not routinely recommended in current guidelines, it has been considered as a potential alternative treatment strategy. Studies on OIT for food allergy have been explored, but no controlled trials have been reported in Japan. Methods: The first oral food challenge (OFC) was performed before treatment to ensure diagnosis and evaluate the threshold dose for egg using the double-blind, placebo-controlled food challenge. Participants were randomly assigned by computerized algorithm to receive OIT using egg (OIT group) or no egg (egg elimination [EE] group). A second OFC was performed in both groups approximately 6 months after therapy. Blood samples were collected and egg white-specific immunoglobulin (Ig)E and IgG4 were measured before and after the treatment period. Results: Eight of the 14 patients (57%) in the OIT group had no allergic reaction to 4 g dry egg powder whereas none of the 16 patients in the EE group did. All 14 patients in the OIT group had increased threshold for egg powder in the second OFC compared with baseline. There was no significant change in egg white-specific IgE level during therapy. After therapy, egg white-specific IgG4 increased significantly in the OIT group, but not in the EE group. Conclusion: OIT is effective in increasing the threshold for allergens and inducing desensitization in Japanese egg allergy patients, similarly to North American and European patients.

Original languageEnglish
JournalPediatrics International
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

Egg Hypersensitivity
Immunotherapy
Ovum
Randomized Controlled Trials
Egg White
Food
Food Hypersensitivity
Powders
Immunoglobulin E
Therapeutics
Immunoglobulin G
Allergens
Japan
Hypersensitivity
Placebos
Guidelines

Keywords

  • Children
  • Egg allergy
  • Immunoglobulin G4
  • Oral immunotherapy
  • Randomized controlled trial

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Akashi, M., Yasudo, H., Narita, M., Nomura, I., Akasawa, A., Ebisawa, M., ... Ohya, Y. (Accepted/In press). Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients. Pediatrics International. https://doi.org/10.1111/ped.13210

Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients. / Akashi, Masayuki; Yasudo, Hiroki; Narita, Masami; Nomura, Ichiro; Akasawa, Akira; Ebisawa, Motohiro; Takahashi, Takao; Ohya, Yukihiro.

In: Pediatrics International, 2017.

Research output: Contribution to journalArticle

Akashi, Masayuki ; Yasudo, Hiroki ; Narita, Masami ; Nomura, Ichiro ; Akasawa, Akira ; Ebisawa, Motohiro ; Takahashi, Takao ; Ohya, Yukihiro. / Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients. In: Pediatrics International. 2017.
@article{cd34952e803a4f2f8d46be43e96ff8b6,
title = "Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients",
abstract = "Background: Egg allergy is one of the most common food allergies in young children. While oral immunotherapy (OIT) is not routinely recommended in current guidelines, it has been considered as a potential alternative treatment strategy. Studies on OIT for food allergy have been explored, but no controlled trials have been reported in Japan. Methods: The first oral food challenge (OFC) was performed before treatment to ensure diagnosis and evaluate the threshold dose for egg using the double-blind, placebo-controlled food challenge. Participants were randomly assigned by computerized algorithm to receive OIT using egg (OIT group) or no egg (egg elimination [EE] group). A second OFC was performed in both groups approximately 6 months after therapy. Blood samples were collected and egg white-specific immunoglobulin (Ig)E and IgG4 were measured before and after the treatment period. Results: Eight of the 14 patients (57{\%}) in the OIT group had no allergic reaction to 4 g dry egg powder whereas none of the 16 patients in the EE group did. All 14 patients in the OIT group had increased threshold for egg powder in the second OFC compared with baseline. There was no significant change in egg white-specific IgE level during therapy. After therapy, egg white-specific IgG4 increased significantly in the OIT group, but not in the EE group. Conclusion: OIT is effective in increasing the threshold for allergens and inducing desensitization in Japanese egg allergy patients, similarly to North American and European patients.",
keywords = "Children, Egg allergy, Immunoglobulin G4, Oral immunotherapy, Randomized controlled trial",
author = "Masayuki Akashi and Hiroki Yasudo and Masami Narita and Ichiro Nomura and Akira Akasawa and Motohiro Ebisawa and Takao Takahashi and Yukihiro Ohya",
year = "2017",
doi = "10.1111/ped.13210",
language = "English",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients

AU - Akashi, Masayuki

AU - Yasudo, Hiroki

AU - Narita, Masami

AU - Nomura, Ichiro

AU - Akasawa, Akira

AU - Ebisawa, Motohiro

AU - Takahashi, Takao

AU - Ohya, Yukihiro

PY - 2017

Y1 - 2017

N2 - Background: Egg allergy is one of the most common food allergies in young children. While oral immunotherapy (OIT) is not routinely recommended in current guidelines, it has been considered as a potential alternative treatment strategy. Studies on OIT for food allergy have been explored, but no controlled trials have been reported in Japan. Methods: The first oral food challenge (OFC) was performed before treatment to ensure diagnosis and evaluate the threshold dose for egg using the double-blind, placebo-controlled food challenge. Participants were randomly assigned by computerized algorithm to receive OIT using egg (OIT group) or no egg (egg elimination [EE] group). A second OFC was performed in both groups approximately 6 months after therapy. Blood samples were collected and egg white-specific immunoglobulin (Ig)E and IgG4 were measured before and after the treatment period. Results: Eight of the 14 patients (57%) in the OIT group had no allergic reaction to 4 g dry egg powder whereas none of the 16 patients in the EE group did. All 14 patients in the OIT group had increased threshold for egg powder in the second OFC compared with baseline. There was no significant change in egg white-specific IgE level during therapy. After therapy, egg white-specific IgG4 increased significantly in the OIT group, but not in the EE group. Conclusion: OIT is effective in increasing the threshold for allergens and inducing desensitization in Japanese egg allergy patients, similarly to North American and European patients.

AB - Background: Egg allergy is one of the most common food allergies in young children. While oral immunotherapy (OIT) is not routinely recommended in current guidelines, it has been considered as a potential alternative treatment strategy. Studies on OIT for food allergy have been explored, but no controlled trials have been reported in Japan. Methods: The first oral food challenge (OFC) was performed before treatment to ensure diagnosis and evaluate the threshold dose for egg using the double-blind, placebo-controlled food challenge. Participants were randomly assigned by computerized algorithm to receive OIT using egg (OIT group) or no egg (egg elimination [EE] group). A second OFC was performed in both groups approximately 6 months after therapy. Blood samples were collected and egg white-specific immunoglobulin (Ig)E and IgG4 were measured before and after the treatment period. Results: Eight of the 14 patients (57%) in the OIT group had no allergic reaction to 4 g dry egg powder whereas none of the 16 patients in the EE group did. All 14 patients in the OIT group had increased threshold for egg powder in the second OFC compared with baseline. There was no significant change in egg white-specific IgE level during therapy. After therapy, egg white-specific IgG4 increased significantly in the OIT group, but not in the EE group. Conclusion: OIT is effective in increasing the threshold for allergens and inducing desensitization in Japanese egg allergy patients, similarly to North American and European patients.

KW - Children

KW - Egg allergy

KW - Immunoglobulin G4

KW - Oral immunotherapy

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=85011676242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011676242&partnerID=8YFLogxK

U2 - 10.1111/ped.13210

DO - 10.1111/ped.13210

M3 - Article

C2 - 27914210

AN - SCOPUS:85011676242

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

ER -